- Home
- TONX vs FBIO Comparison
TONX vs FBIO Comparison
Compare TONX & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TONX | FBIO |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.5M | 113.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TONX | FBIO |
|---|---|---|
| Price | $2.87 | $3.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 640.6K | ★ 1.2M |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 7.29 | N/A |
| Revenue | $7,760,000.00 | ★ $62,303,000.00 |
| Revenue This Year | $526.82 | $29.71 |
| Revenue Next Year | $45.45 | $49.34 |
| P/E Ratio | $0.39 | ★ N/A |
| Revenue Growth | ★ 3760.70 | N/A |
| 52 Week Low | $1.88 | $1.33 |
| 52 Week High | $29.77 | $4.53 |
Technical Indicators
Market Signals| Indicator | TONX | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 52.72 |
| Support Level | N/A | $3.25 |
| Resistance Level | N/A | $4.53 |
| Average True Range (ATR) | 0.00 | 0.32 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 0.00 | 38.88 |
Price Performance
Historical ComparisonAbout TONX TON Strategy Company
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.